HDV: Thirty years later

Digestive and Liver Disease

Volumn 43, Issue SUPPL. 1, 2011, Pages

  Smedile, Antonina ^a   Rizzetto, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Chronic liver disease; HDV; Hepatitis D; Hepatitis delta virus

Indexed keywords

VIRUS RNA;

AFRICA; ARTICLE; ASIA; DELTA AGENT HEPATITIS; DISEASE COURSE; ENDEMIC DISEASE; HEPATITIS DELTA VIRUS; HUMAN; MIGRANT BIRD; NONHUMAN; PRIORITY JOURNAL; SOUTH AFRICA; VIRUS GENOME;

ANIMALS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D; HEPATITIS DELTA ANTIGENS; HEPATITIS DELTA VIRUS; HUMANS; RNA, VIRAL;

EID: 78650648474     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(10)60687-1     Document Type: Article

References (21)

1. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977, 18:997-1003.
2. Rizzetto M, Canese MG, Gerin JL, et al. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980, 141:590-602.
3. Rizzetto M, Hoyer B, Canese MG, et al. delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci USA 1980, 77:6124-6128.
4. Murphy FA Virus taxonomy. Fields virology 1996, Raven Press, New York. 3rd edn. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
5. Dény P Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades?. Curr Top Microbiol Immunol 2006, 307:151-171.
6. Been MD HDV ribozymes. Curr Top Microbiol Immunol 2006, 307:47-65.
7. Taylor JM Chapter 3. Replication of the hepatitis delta virus RNA genome. Adv Virus Res 2009, 74:103-121.
8. Lai MM RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol 2005, 79:7951-7958.
9. Smedile A, Rizzetto M, Gerin JL Advances in hepatitis D virus biology and disease. Progress in Liver Disease 1994, Vol. XII:157-175. Saunders Company. J.L. Boyer, R.K. Ockner (Eds.).
10. Fattovich G, Giustina G, Christensen E, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European concerted action on viral hepatitis. Gut 2000, 46:420-426.
11. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 2000, 32:824-827.
12. Navascués CA, Rodríguez M, Sotorrío NG, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 1995, 90:1981-1984.
13. Deĝertekin H, Yalçin K, Yakut M The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies. Turk J Gastroenterol 2006, 17:25-34.
14. Stroffolini T, Almasio PL, Sagnelli E, et al. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study. J Med Virol 2009, 81:1999-2006. Italian Hospitals' Collaborating Group.
15. Cross TJS, Rizzi P, Horner M, et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008, 80:277-282.
16. Wedemeyer H, Heidrich B, Manns MP Hepatitis D virus infection - not a vanishing disease in Europe!. Hepatology 2007, 45:1331-1332.
17. Rosina F, Conoscitore P, Cuppone R, et al. Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology 1999, 117:161-166.
18. Buti M, Homs M, Rodriguez-Frias F, et al. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow up study. J Viral Hepat, in press.
19. Niro GA, Rosina F, Rizzetto M Treatment of hepatitis D. J Viral Hepat 2005, 12:2-9.
20. Glenn JS Prenylation of HDAg and antiviral drug development. Curr Top Microbiol Immunol 2006, 307:133-149.
21. Urban S, Schulze A, Schieck A, et al. Preclinical studies on myrcludex b, a novel entry inhibitor for hepatitis b- and hepatitis delta virus (HDV) infections. J Hepatol 2010, 52:S1-21.